Progyny (PGNY) | Stock Overview & Key Data
Progyny Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $68.32 on November 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Progyny
PGNY
|
1.45B Small-cap | 3.82% | 15.74% | 54.48% | 2.16% | 4.55% | 26.63% | -31.61% | -58.69% | 67.06% | 67.06% | 67.06% |
|
UnitedHealth
UNH
|
322.34B Mega-cap | 1.10% | 4.36% | 43.98% | 20.50% | 22.19% | 30.30% | -10.90% | 4.92% | 196.70% | 717.69% | 822.38% |
|
CVS Health
CVS
|
101.07B Large-cap | 3.71% | 5.00% | 32.75% | 26.34% | 25.65% | 51.14% | 50.56% | 23.74% | 7.51% | 173.13% | 237.73% |
|
Clover Health
CLOV
|
1.26B Small-cap | 22.70% | 38.62% | 144.16% | 83.59% | 99.59% | 64.24% | 425.56% | -60.71% | -53.63% | -53.63% | -53.63% |
|
Elevance Health
ELV
|
76.43B Large-cap | -3.89% | 2.35% | 37.60% | 11.43% | 13.45% | 5.08% | -8.83% | 9.44% | 205.33% | 430.00% | 468.71% |
|
Cigna
CI
|
72.68B Large-cap | 1.46% | 3.00% | 9.50% | 6.02% | 5.27% | -6.11% | 10.85% | 28.46% | 130.12% | 509.53% | 856.66% |
Ownership & Short Interest
Calculate Your Progyny Investment Returns
Long-Term Investment Performance Analysis
Progyny stock price in Oct 2019 was $15.94, A $1,000.00 lump sum investment in Progyny made 6 years ago would be worth approximately $1,688.21 today, representing a solid return of 68.82%. This translates to an annualized return (CAGR) of 8.19%.
6 Years 7 Months Investment Scenario (Oct 2019 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PGNY's 52-week high and low?
- In the last 52 weeks, Progyny reached a high of $28.75 (on January 13, 2026) and a low of $16.10 (on April 10, 2026).
- What is the market cap and P/E ratio for PGNY?
- Curious about Progyny's size and valuation? Its market capitalization stands at 1.45B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.18, and the forward P/E (looking ahead) is 8.41.
- Does PGNY pay dividends? If so, what's the yield?
- As for dividends, Progyny isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Progyny's main competitors or similar companies to consider before investing?
When looking at Progyny, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH322.34B Healthcare Healthcare Plans 30.30% -10.90% CVS Health
CVS101.07B Healthcare Healthcare Plans 51.14% 50.56% Clover Health
CLOV1.26B Healthcare Healthcare Plans 64.24% 425.56% Elevance Health
ELV76.43B Healthcare Healthcare Plans 5.08% -8.83% Cigna
CI72.68B Healthcare Healthcare Plans -6.11% 10.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Progyny Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Progyny's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.48%, the Debt to Equity ratio from the most recent quarter is 5.37, and its Gross Profit Margin stands at 24.15%.
- What is the recent revenue and earnings growth for PGNY?
- Looking at Progyny's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.70%, and quarterly earnings saw a YoY growth of 18.50%.
- How much of PGNY stock is held by insiders and institutions?
- Wondering who owns Progyny stock? Company insiders (like executives and directors) hold about 1.91% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 114.23%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.